Literature DB >> 2456624

Pituitary adenomas in Cushing's disease: do they arise from the intermediate lobe?

C Raffel1, J E Boggan, L F Eng, R L Davis, C B Wilson.   

Abstract

Pituitary adenomas from 15 patients with Cushing's disease were studied histopathologically. The tumors were examined for the presence of neural axons by the Bodian silver impregnation technique and a specific immunohistologic technique based on a monoclonal antibody to axonal neurofilaments. Axons were not seen in any of the surgical specimens. This finding suggests that most, if not all, adrenocorticotropin-secreting pituitary adenomas are of anterior lobe origin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456624     DOI: 10.1016/0090-3019(88)90097-3

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  4 in total

1.  From macroprolactinoma to concomitant ACTH-PRL hypersecretion with Cushing's disease.

Authors:  M Barausse; R Attanasio; D Dallabonzana; G Oppizzi; S Veronese; G Lasio; L G Valentini; R Cozzi
Journal:  J Endocrinol Invest       Date:  2000-02       Impact factor: 4.256

2.  Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.

Authors:  R G Gheri; W Boddi; F Ammannati; J Olivotto; C Nozzoli; A Franchi; L Bordi; M L Luisi; P Mennonna
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

3.  Macroprolactinoma associated with Cushing's disease, successfully treated with cabergoline.

Authors:  G T'Sjoen; I Defeyter; J Van De Saffele; R Rubens; M Vandeweghe
Journal:  J Endocrinol Invest       Date:  2002-02       Impact factor: 4.256

4.  Long-term quiescence of ectopic Cushing's syndrome caused by pulmonary neuroendocrine tumor (typical carcinoid) and tumorlets: spontaneous remission or therapeutic effect of bromocriptine?

Authors:  G Francia; M V Davì; E Montresor; C Colato; M Ferdeghini; V Lo Cascio
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 5.467

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.